SC 13G/A: MACROGENICS INC
Ticker: MGNX · Form: SC 13G/A · Filed: 2024-10-22T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by MACROGENICS INC.
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0002012383-24-001300 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0002012383-24-001300 Filing Date 2024-10-22 Accepted 2024-10-22 15:24:03 Documents 1 Document Format Files Seq Description Document Type Size 1 us5560991094_102224.txt SC 13G/A 12065 Complete submission text file 0002012383-24-001300.txt 13773 Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172 MACROGENICS INC (Subject) CIK : 0001125345 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-87928 | Film No.: 241386124 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences) Mailing Address 50 HUDSON YARDS NEW YORK NY 10001 Business Address 50 HUDSON YARDS NEW YORK NY 10001 (212) 810-5300 BlackRock, Inc. (Filed by) CIK : 0002012383 (see all company filings) EIN. : 991116001 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A SIC : 6211 Security Brokers, Dealers & Flotation Companies (CF Office: 02 Finance)